[go: up one dir, main page]

FI881525A7 - Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi

Info

Publication number
FI881525A7
FI881525A7 FI881525A FI881525A FI881525A7 FI 881525 A7 FI881525 A7 FI 881525A7 FI 881525 A FI881525 A FI 881525A FI 881525 A FI881525 A FI 881525A FI 881525 A7 FI881525 A7 FI 881525A7
Authority
FI
Finland
Prior art keywords
arylpiperazineacetamide
derivatives
therapeutically useful
preparing novel
novel therapeutically
Prior art date
Application number
FI881525A
Other languages
English (en)
Swedish (sv)
Other versions
FI97617C (fi
FI97617B (fi
FI881525A0 (fi
Inventor
Daele Georges Henri Paul Van
Freddy Francois Vlaeminck
Marc Gustaaf Celine Verdonck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI881525A0 publication Critical patent/FI881525A0/fi
Publication of FI881525A7 publication Critical patent/FI881525A7/fi
Application granted granted Critical
Publication of FI97617B publication Critical patent/FI97617B/fi
Publication of FI97617C publication Critical patent/FI97617C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
FI881525A 1987-04-01 1988-03-31 Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi FI97617C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3412987A 1987-04-01 1987-04-01
US3412987 1987-04-01

Publications (4)

Publication Number Publication Date
FI881525A0 FI881525A0 (fi) 1988-03-31
FI881525A7 true FI881525A7 (fi) 1988-10-02
FI97617B FI97617B (fi) 1996-10-15
FI97617C FI97617C (fi) 1997-01-27

Family

ID=21874492

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881525A FI97617C (fi) 1987-04-01 1988-03-31 Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi

Country Status (21)

Country Link
EP (2) EP0285219B1 (fi)
JP (1) JP2574377B2 (fi)
KR (1) KR960016539B1 (fi)
AT (2) ATE142627T1 (fi)
AU (1) AU609790B2 (fi)
CA (1) CA1315790C (fi)
DE (2) DE3856501T2 (fi)
DK (1) DK174878B1 (fi)
ES (2) ES2091183T3 (fi)
FI (1) FI97617C (fi)
GR (1) GR3020983T3 (fi)
HK (1) HK1006020A1 (fi)
HU (2) HUT57740A (fi)
IE (1) IE81057B1 (fi)
IL (1) IL85919A (fi)
NO (1) NO178660C (fi)
NZ (1) NZ223847A (fi)
PH (1) PH25507A (fi)
PT (1) PT87118B (fi)
RU (1) RU2014328C1 (fi)
ZA (1) ZA882352B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0577171T3 (da) * 1989-11-22 2002-06-03 Janssen Pharmaceutica Nv Anvendelse af piperazinacetamidderivater mod reperfusionsskader
US5840896A (en) * 1989-11-22 1998-11-24 Janssen Pharmaceutica, N.V. Method of preventing or limiting reperfusion damage
JP2660086B2 (ja) * 1990-07-03 1997-10-08 明治製菓株式会社 脳及び心機能障害改善剤
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
NZ240863A (en) * 1991-09-11 1995-04-27 Mcneilab Inc Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof
ES2125285T3 (es) * 1992-07-31 1999-03-01 Bristol Myers Squibb Co Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles.
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
DK0756593T3 (da) * 1994-04-20 2000-11-13 Lonza Ag Fremgangsmåde til fremstilling af 2-piperazincarboxylsyrederivater
US5866574A (en) * 1997-04-10 1999-02-02 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
EP0999840B1 (en) * 1997-06-16 2003-05-02 Janssen Pharmaceutica N.V. Use of a draflazine analogue for treating pain
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
DK1836179T3 (en) 2004-12-30 2015-05-26 Janssen Pharmaceutica Nv PIPERIDINE AND PIPERAZINE-1-CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF FAT ACID AMIDE HYDRALASE (FAAH) FOR THE TREATMENT OF ANCIENT, PAIN AND OTHER CONDITIONS
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN110511220B (zh) * 2018-05-22 2022-04-01 上海挚盟医药科技有限公司 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia

Also Published As

Publication number Publication date
GR3020983T3 (en) 1996-12-31
CA1315790C (en) 1993-04-06
NZ223847A (en) 1989-12-21
FI97617C (fi) 1997-01-27
KR880012566A (ko) 1988-11-28
IE81057B1 (en) 1999-12-29
HUT57740A (en) 1991-12-30
ATE207474T1 (de) 2001-11-15
KR960016539B1 (ko) 1996-12-14
EP0285219A3 (en) 1991-07-03
DK174878B1 (da) 2004-01-12
DK179788A (da) 1988-10-02
IL85919A0 (en) 1988-09-30
FI97617B (fi) 1996-10-15
DK179788D0 (da) 1988-03-30
ZA882352B (en) 1989-12-27
RU2014328C1 (ru) 1994-06-15
HU211129A9 (en) 1995-10-30
NO881407L (no) 1988-10-03
FI881525A0 (fi) 1988-03-31
PT87118A (pt) 1988-04-01
ATE142627T1 (de) 1996-09-15
AU1384788A (en) 1988-10-06
DE3855520D1 (de) 1996-10-17
NO178660B (no) 1996-01-29
IL85919A (en) 1992-12-01
DE3855520T2 (de) 1997-02-06
EP0727421A1 (en) 1996-08-21
JPS63290869A (ja) 1988-11-28
EP0285219A2 (en) 1988-10-05
NO178660C (no) 1996-05-08
EP0285219B1 (en) 1996-09-11
AU609790B2 (en) 1991-05-09
DE3856501T2 (de) 2004-04-29
JP2574377B2 (ja) 1997-01-22
HK1006020A1 (en) 1999-02-05
ES2167510T3 (es) 2002-05-16
DE3856501D1 (de) 2001-11-29
IE880989L (en) 1988-10-01
PH25507A (en) 1991-07-24
NO881407D0 (no) 1988-03-29
ES2091183T3 (es) 1996-11-01
PT87118B (pt) 1992-07-31
EP0727421B1 (en) 2001-10-24

Similar Documents

Publication Publication Date Title
FI885409A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI881180L (fi) Menetelmä terapeuttisesti käytettävien tetrahydronaftaleenijohdannaisten valmistamiseksi
FI883249A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
FI883064A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI893433A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI880816A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten kinoksaliinijohdannaisten valmistamiseksi
FI883388L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
FI906438L (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
BG49939A3 (bg) Метод за получаване на 2-анилино-пиримидинови производни
FI884627A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten dideoksisytidiinijohdannaisten valmistamiseksi
FI883603A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI884553A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
FI891339A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
FI890283A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI883672A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI883889A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
FI894803L (fi) Menetelmä terapeuttisesti käyttökelpoisten kinolinonijohdannaisten valmistamiseksi
FI884910A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI883997L (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
FI880467A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI881525A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi
FI885560A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Owner name: JANSSEN PHARMACEUTICA N.V.

BB Publication of examined application
FG Patent granted

Owner name: JANSSEN PHARMACEUTICA N.V.

MA Patent expired